We are live on
!
Find out more
TCM
Tufton Capital Management Portfolio holdings
AUM
$596M
1-Year Est. Return
37.37%
This Fund
S&P 500
This Quarter
Est. Return
+1.72%
1 Year Est. Return
+37.37%
3 Year Est. Return
+86.54%
5 Year Est. Return
+98.63%
10 Year Est. Return
+299.31%
AUM
$493M
AUM Growth
-$14.7M
(-2.9%)
Cap. Flow
-$21.8M
Cap. Flow
% of AUM
-4.42%
Top 10 Holdings %
Top 10 Hldgs %
30.85%
Holding
131
New
6
Increased
29
Reduced
61
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.76M |
| 2 |
Helmerich & Payne
HP
|
+$1.29M |
| 3 |
Verizon
VZ
|
+$648K |
| 4 |
DXC Technology
DXC
|
+$592K |
| 5 |
Chesapeake Utilities
CPK
|
+$504K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McCormick & Company Voting
MKC.V
|
+$20.2M |
| 2 |
JPMorgan Chase
JPM
|
+$1.58M |
| 3 |
Norfolk Southern
NSC
|
+$1.37M |
| 4 |
Oracle
ORCL
|
+$1.27M |
| 5 |
Microsoft
MSFT
|
+$880K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 23.46% |
| 2 | Industrials | 15.44% |
| 3 | Technology | 13.96% |
| 4 | Healthcare | 11.57% |
| 5 | Financials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
McCormick & Company Voting
MKC.V
$13.7B
| $38.4M | 7.79% |
786,390
-400,000
| -34% | -$20.2M |
|
|
2
McCormick & Company Non-Voting
MKC
$13.7B
| $16.8M | 3.4% |
343,684
| – | – |
|
|
3
Microsoft
MSFT
$3.45T
| $13.2M | 2.67% |
190,965
-12,818
| -6% | -$880K |
|
4
ExxonMobil
XOM
$644B
| $13.1M | 2.65% |
161,657
+4,480
| +3% | +$367K |
|
|
5
JPMorgan Chase
JPM
$935B
| $13M | 2.64% |
142,163
-18,360
| -11% | -$1.58M |
|
|
6
Oracle
ORCL
$374B
| $12.4M | 2.51% |
246,672
-27,915
| -10% | -$1.27M |
|
7
GE Aerospace
GE
$374B
| $12.4M | 2.51% |
95,452
-82
| -0.1% | -$11.2K |
|
8
Johnson & Johnson
JNJ
$618B
| $11.4M | 2.31% |
86,042
-3,065
| -3% | -$391K |
|
9
Merck
MRK
$322B
| $11.4M | 2.31% |
185,934
+1,205
| +0.7% | +$73.4K |
|
10
Intel
INTC
$455B
| $10.2M | 2.07% |
301,986
-1,735
| -0.6% | -$62.1K |
|
11
AbbVie
ABBV
$443B
| $10M | 2.04% |
138,585
-546
| -0.4% | -$36.7K |
|
12
Procter & Gamble
PG
$336B
| $9.67M | 1.96% |
110,922
-1,075
| -1% | -$94.8K |
|
|
13
Bristol-Myers Squibb
BMY
$133B
| $9.46M | 1.92% |
169,684
+32,310
| +24% | +$1.76M |
|
14
RTX Corp
RTX
$290B
| $9.17M | 1.86% |
119,331
-1,041
| -0.9% | -$78K |
|
15
Lockheed Martin
LMT
$134B
| $9.1M | 1.85% |
32,780
-55
| -0.2% | -$15.1K |
|
16
Wells Fargo
WFC
$261B
| $8.96M | 1.82% |
161,747
+1,570
| +1% | +$84.1K |
|
|
17
Norfolk Southern
NSC
$75.4B
| $8.86M | 1.8% |
72,832
-11,655
| -14% | -$1.37M |
|
|
DD
18
DELISTED
Du Pont De Nemours E I
DD
| $8.71M | 1.77% |
107,917
-5,800
| -5% | -$464K |
|
19
Target
TGT
$65.6B
| $8.66M | 1.76% |
165,641
+5,685
| +4% | +$311K |
|
|
20
Chesapeake Utilities
CPK
$3.19B
| $8.56M | 1.74% |
114,179
+6,900
| +6% | +$504K |
|
21
Emerson Electric
EMR
$83.9B
| $8.43M | 1.71% |
141,349
-160
| -0.1% | -$9.49K |
|
22
Alphabet (Google) Class C
GOOG
$4.36T
| $8.4M | 1.7% |
184,880
-5,560
| -3% | -$255K |
|
23
Caterpillar
CAT
$375B
| $8.35M | 1.69% |
77,705
-265
| -0.3% | -$26.9K |
|
24
Automatic Data Processing
ADP
$106B
| $7.97M | 1.62% |
77,765
-485
| -0.6% | -$49.1K |
|
25
Harley-Davidson
HOG
$2.58B
| $7.47M | 1.52% |
138,362
+3,505
| +3% | +$195K |
|
Similar funds
BWP
TAIM
BCM
ECM
FSG
ESL
SCM
GP
Tufton Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Tufton Capital Management held 131 positions worth $493M, down 2.9% from $507M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Tufton Capital Management withdrew a net $21.8M in Q2 2017, closing 4 positions and reducing 61 holdings. Its most notable exit was Vanguard FTSE Developed Markets ETF, an estimated $609K position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, down from 26% a quarter earlier, followed by Industrials and Technology.
Against the trend, Tufton Capital Management opened a new position in DXC Technology worth $592K.
- Tufton Capital Management's largest Q2 2017 buy was DXC Technology: 8,920 shares worth $592K.
- Tufton Capital Management added most to Bristol-Myers Squibb in Q2 2017, an estimated $1.76M increase.
- Tufton Capital Management's biggest Q2 2017 reduction was McCormick & Company Voting, cutting an estimated $20.2M.
- Tufton Capital Management fully exited Vanguard FTSE Developed Markets ETF in Q2 2017, selling an estimated $609K.
- Tufton Capital Management's ten largest holdings make up 31% of its $493M portfolio in Q2 2017.
- Tufton Capital Management opened 6 new positions and closed 4 in Q2 2017.
- Tufton Capital Management's portfolio value fell 2.9% quarter-over-quarter to $493M.
Based on Tufton Capital Management's 13F filing for Q2 2017, filed 28 Jul 2017.